scholarly journals No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15

2013 ◽  
Vol 164 (3) ◽  
pp. 376-383 ◽  
Author(s):  
Motohiro Kato ◽  
Katsuyoshi Koh ◽  
Atsushi Manabe ◽  
Tomohiro Saito ◽  
Daisuke Hasegawa ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
Randomized Trial ◽  
Lymphoblastic Leukaemia ◽  
High Dose ◽  
Intermediate Risk ◽  
High Dose Cytarabine

scholarly journals Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults

2017 ◽  
Vol 178 (1) ◽  
pp. 106-111 ◽  
Author(s):  
Yasuyuki Arai ◽  
Tadakazu Kondo ◽  
Akio Shigematsu ◽  
Junji Tanaka ◽  
Kazuteru Ohashi ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
Lymphoblastic Leukaemia ◽  
High Dose ◽  
High Dose Cytarabine

scholarly journals High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia

2002 ◽  
Vol 118 (3) ◽  
pp. 748-754 ◽  
Author(s):  
Helene Hallböök ◽  
Bengt Simonsson ◽  
Thomas Ahlgren ◽  
Magnus Björkholm ◽  
Jan Carneskog ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
Lymphoblastic Leukaemia ◽  
Adult Patients ◽  
High Dose ◽  
High Dose Cytarabine ◽  
Upfront Therapy
Sign in / Sign up

Export Citation Format

Share Document